行情

GKOS

GKOS

Glaukos
NYSE

实时行情|Nasdaq Last Sale

30.52
+0.27
+0.89%
盘后: 30.52 0 0.00% 16:24 04/07 EDT
开盘
32.04
昨收
30.25
最高
32.29
最低
29.68
成交量
69.45万
成交额
--
52周最高
84.65
52周最低
23.31
市值
13.35亿
市盈率(TTM)
348.40
分时
5日
1月
3月
1年
5年

分析师评级

10位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测GKOS价格均价为49.50,最高价位62.00,最低价为36.00。

EPS

GKOS 新闻

更多
  • 特朗普:英国请求美提供200台呼吸机 我们会帮他们解决
  • 环球网 · 19分钟前
  • 古特雷斯决定暂停联合国维和人员轮换及部署
  • 新华网 · 28分钟前
  • 爱奇艺也被做空!被指虚增收入超80亿 "坚决否认"指控
  • 澎湃新闻 · 29分钟前
  • Facebook面向情侣发布新聊天应用 可记录爱情时间线
  • 新浪科技 · 42分钟前

所属板块

医疗设备、用品及经销
-0.68%
医疗设备和用品
-0.82%

热门股票

代码
价格
涨跌幅

GKOS 简况

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm's canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream. It is developing three additional pipeline products: the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is a drug delivery system that is designed to be implanted in the eye to continuously deliver therapeutic levels of medication for extended periods of time to lower intraocular pressure in glaucoma patients.
展开

微牛提供Glaukos Corp(NYSE-GKOS)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的GKOS股票新闻,以帮助您做出投资决策。